Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06602232 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo

StatusActive, Not Recruiting
PhasePhase 1
SponsorDren Bio
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Re-verified, no change to tracked fieldsv16
  2. Notable Primary and study completion dates: Sep 2026 to May 2027
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 80 to confirmed 81
    • Site details revised at 20 of 20 sites
    v15
  3. Minor Site details revised at 20 of 20 sitesv14
  4. Minor Re-verified, no change to tracked fieldsv13
  5. Minor Site details revised at 2 of 20 sitesv12
Show 10 earlier versionsHide 10 earlier versions
  1. Minor Enrollment target: 60 to 80
    • Study arms: 3 to 4
    v11
  2. Minor Study sites: 22 to 20v10
  3. Minor Study sites: 23 to 22v9
  4. Minor Study sites: 24 to 23v8
  5. Minor Start date changed from estimate of Oct 2024 to Oct 30, 2024v7
  6. Minor Study sites: 21 to 24v6
  7. Minor Site details revised at 2 of 21 sitesv5
  8. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Sep 2024 to Oct 2024
    • Site details revised at 21 of 21 sites
    v4
  9. Minor Study sites: 13 to 21v3
  10. Minor Re-verified, no change to tracked fieldsv2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
4 trials monitored
See 1 trial at risk
This is a multi-center, parallel-group, open-label, randomized, Phase 1b study to explore the safety, clinical activity, pharmacokinetics and pharmacodynamics of DR-01 in adults with Alopecia Areata or Vitiligo.
Trial Details
NCT Number NCT06602232
Lead Sponsor Dren Bio
Conditions
(from sponsor)
Alopecia Areata, Vitiligo
Related terms Alopecia, Alopecia Areata, Hair Diseases, Skin Diseases, Vitiligo
Enrollment 81 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov